What is the appropriate treatment for vertigo?

Treatment for Vertigo

For benign paroxysmal positional vertigo (BPPV)—the most common cause of vertigo—perform canalith repositioning procedures (Epley or Semont maneuvers) immediately at the bedside, which achieve approximately 80% success rates with 1-3 treatments and directly improve quality of life by resolving symptoms and reducing fall risk. 1

Diagnostic Framework First

Before treating vertigo, distinguish the type:

• Positional triggers (worse with head movement, rolling over in bed): BPPV
• Spontaneous episodes with hearing loss: Ménière's disease
• Acute continuous vertigo without hearing loss: Vestibular neuritis
• Central symptoms (diplopia, dysarthria, ataxia, focal weakness): Stroke or CNS pathology

Use the Dix-Hallpike test for posterior canal BPPV (85-95% of cases) and the supine roll test for lateral canal BPPV (5-15% of cases) 1, 2. The HINTS examination (head impulse, nystagmus, test of skew) distinguishes dangerous central causes from benign peripheral causes 3, 2.

Treatment by Etiology

BPPV (Most Common)

Canalith repositioning procedures are the definitive treatment:

• Epley maneuver for posterior canal BPPV
• Semont maneuver as alternative for posterior canal
• Gufoni maneuver or modified techniques for lateral canal BPPV 1

These maneuvers physically guide displaced otoconia (calcium crystals) back to their proper location. Success rates reach 86-100% with up to 4 treatments for lateral canal BPPV 1.

Avoid vestibular suppressant medications (antihistamines, benzodiazepines, anticholinergics) except for immediate severe nausea relief, as they delay natural compensation and prolong recovery 1, 4. These drugs do not treat the underlying mechanical problem.

Teach patients self-repositioning maneuvers under supervision for home use, particularly beneficial for those with recurrence risk 1.

Vestibular Neuritis

• Brief vestibular suppressants only (2-3 days maximum): diazepam 10 mg IM once or twice daily, or equivalent benzodiazepines 5
• Early vestibular rehabilitation therapy is critical—prolonged suppressant use impairs compensation 2, 4
• Symptoms typically resolve over weeks with proper rehabilitation

Ménière's Disease

• Salt restriction (< 2 grams sodium daily)
• Diuretics for prophylaxis 2, 4
• Vestibular suppressants only during acute attacks
• For refractory cases, consider endolymphatic duct blockage or sac drainage over decompression (better long-term vertigo control and hearing preservation) 6

Vestibular Migraine

Prophylactic medications are the mainstay:

• L-type calcium channel antagonists (first-line)
• Tricyclic antidepressants
• Beta-blockers 4

Avoid treating with vestibular suppressants alone—address the underlying migraine pathophysiology.

Critical Management Points

If BPPV treatment fails after 3-4 attempts:

1. Reassess with Dix-Hallpike and supine roll tests—may have wrong canal identified 1
2. Check for "canal conversion" (posterior ↔ lateral canal, occurs in ~6% of cases) 1
3. Consider multicanal involvement (rare but possible)
4. Rule out coexisting vestibular dysfunction (head trauma, vestibular neuritis history) 1
5. Consider central causes (3% of treatment failures have CNS disorders) 1

High-risk populations requiring immediate specialist referral:

• Elderly with fall history or fear of falling
• Severe disabling symptoms
• Limited mobility or neck/back stiffness 1

Vestibular Rehabilitation

Initiate early for:

• Vestibular neuritis (essential for compensation)
• Persistent symptoms after successful BPPV repositioning
• Bilateral vestibular loss
• Residual dizziness lasting ≥7 days post-BPPV treatment 7

Vestibular rehabilitation is a protective factor against prolonged residual dizziness (OR = 0.197) 7.

Patient Education Essentials

Counsel patients on:

• Recurrence risk: BPPV recurs commonly; symptoms naturally decrease over time but untreated episodes increase fall risk 1
• Post-treatment expectations: Mild motion sensitivity and unsteadiness may persist for days to weeks after successful repositioning 1
• Safety precautions: Increased fall risk during symptomatic periods, especially in elderly 1
• Self-treatment options: Supervised home maneuvers for recurrence 1

Common Pitfalls to Avoid

1. Do not prescribe meclizine or other vestibular suppressants for BPPV—they delay recovery without addressing the mechanical problem 1
2. Do not order routine imaging (CT/MRI) for typical BPPV presentation—diagnosis is clinical 2
3. Do not use prolonged vestibular suppressants for vestibular neuritis—impairs central compensation 4
4. Do not assume treatment failure means wrong diagnosis—check for canal conversion or multicanal involvement first 1

Risk factors for prolonged residual dizziness (≥7 days) after BPPV treatment: older age (OR = 1.054), diabetes mellitus (OR = 5.564), and depression (OR = 9.070) 7. These patients need closer follow-up and early vestibular rehabilitation.